Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Artificial Intelligence
Biotech
Merck bags options on Evaxion's AI-designed vaccine candidates
Merck dangled more than $1 billion in milestones for options on preclinical prospects against gonorrhea and an undisclosed infectious agent.
Nick Paul Taylor
Sep 26, 2024 7:30am
Generate gains another $1B-plus Big Pharma partner in Novartis
Sep 24, 2024 6:00am
Rakovina deepens AI focus with collab to select cancer targets
Sep 17, 2024 9:20am
SpectraWAVE collects $50M for coronary imaging catheters and AI
Sep 11, 2024 8:00am
Gilead inks $35M collab with AI drug discovery outfit Genesis
Sep 10, 2024 11:40am
AZ outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC
Sep 8, 2024 12:22pm